- News & Analysis
- Home
- Latest News
- Reports
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Job Postings
- Events
Page 201
Pichette parts ways with OSI
Oxford Sciences Innovation has bid farewell to chairman Patrick Pichette, just a few months after also losing CEO Charles Conn.
Feb 11, 2020Stilla sets up $21.8m series B
Paris Saclay Seed Fund and all other existing backers returned for the series B round, which additionally attracted Tsinghua University’s TUS Holdings.
Feb 11, 2020TactoTek forges $25.3m series C
Cornes, 3M Ventures and Repsol Energy Ventures contributed to a round that increased the VTT-founded in-mold structural electronics provider's total funding to more than $59m.
Feb 10, 2020Sonoma sends for Lyell in $40m series A
Sonoma Biotherapeutics has emerged from stealth with $40m to develop regulatory T-cell therapies for autoimmune and degenerative diseases.
Feb 10, 2020PSL Innovation Fund graduates with $83.2m
The deep tech-focused commercialisation vehicle currently has 10 portfolio companies having smashed its original $54.8m fundraising target.
Feb 10, 2020Daily deal net: February 7, 2020
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Feb 7, 2020Lange lunges into PRF position
Wade Lange is Purdue Research Foundation's new vice-president and chief entrepreneurial officer, having previously served as Purdue Foundry's entrepreneur-in-residence.
Feb 7, 2020Lunaphore hones series C pitch
EPFL-founded tissue analysis technology developer Lunaphore has now raised $37.3m in all after a series C round led by medical products firm PHC Holdings.
Feb 7, 2020BenchSci sits down investors to raise $22m
Existing investor Gradient Ventures invested in a series B round that almost doubled the clinical research software provider's overall funding to $45m.
Feb 6, 2020Verana charts course to $100m
Oak Ridge spinout Verana Health has completed a $100m round led by existing investor GV that will help it expand its clinical database platform into new areas.
Feb 6, 2020About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits our membership, providing privileged access to all our services and resources.
Navigation
test regLogin
Not yet subscribed?
We use cookies to enhance your browsing experience and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.


